Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ebastine for adult hospitalized patients with COVID-19
ChiCTR2000030535Phase 4Recruiting
- Sponsor
- Wuhan Red Cross Hospital
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of eribulin in coronavirus disease 2019 (COVID-19) and coronavirus pneumonia (2 arms), sponsored by Wuhan Red Cross Hospital. Primary endpoints: Clinical therapeutic course, Pathogenic detection and 2 more. Started Feb 2020; status: recruiting.
02
Drugs
eribulin
03
Conditions
coronavirus disease 2019 (COVID-19)coronavirus pneumonia
Beyond the preview
Go deeper on ChiCTR2000030535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030535.